Industry Briefs: Mar. 19, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Mar. 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Bend Reasearch has launched a biotherapeutics-development initiative. Read More

OctoPlus has formed an agreement with a top-five generic-drugs company for the development of a formulation for an injectable drug. Read More

QRxPharma has signed a license and option agreement with Actavis. Read More

Recipharm has been contracted by ViroPharma to complete a full commercial scale-up manufacture of DuoCort’s Plenadren (hydrocortisone modified-release tablet). Read More

Shire plans to acquire FerroKin BioSciences for an upfront payment of $100 million. Read More

ThromboGenics has formed a commercialization agreement for Ocriplasmin with Alcon. Read More

People News

Stuart E. Needleman has been named president and chief operating officer of Aptuit, effective immediately. Read More

Avanir Pharmaceuticals has appointed Rohan Palekar as chief commercial officer. Read More

Unigene has appointed David Moskowitz as chief financial officer. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here